TRUP
Trupanion, Inc. (NASDAQ)
Financial Services — Insurance - Property & Casualty
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.
Buy
2.2 / 5
4 analysts
$26.46
+$0.31 (+1.19%)
Target:
$39.75
(50.2%)
Sign in to add TRUP to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | $1.15B |
| P/E Ratio (TTM) | 44.85 |
| Forward P/E | 6.14 |
| EPS (TTM) | $0.59 |
| Dividend Yield | - |
| Profit Margin | 1.74% |
| Revenue Growth | 12.30% |
| ROE | 7.08% |
| Debt/Equity | 27.70 |
| Recommendation | Buy 2.2 |
| Analyst Target | $39.75 |
| Analysts | 4 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 72.9 |
| Beta | 1.43 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $57.00 |
| 52-Week Low | $21.16 |
| 50-Day Avg | $23.82 |
| 200-Day Avg | $31.99 |
| Avg Volume | 394.0K |
| Volume | 5.2K |
Performance Analysis
NEUTRALTRUP presents a mixed picture with both positive and negative indicators.
~
Trading at 15% of its 52-week range.
-
RSI at 72.9 indicates overbought conditions — a pullback may be due.
-
P/E of 44.8 is elevated — the market expects high growth or it may be overvalued.
~
Modest revenue growth of 12.3% year-over-year.
+
Wall Street consensus is "Buy" from 4 analysts.
+
Average analyst target of $39.75 implies 50.2% upside.
Recent News
Loading news...
Last updated: Jul 02, 2026 13:35 UTC
Back to Screener Export Report